LMR Partners LLP

SEC CIK: 0001578621
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

CLDX holding history

Celldex Therapeutics, Inc. in every 13F filed by LMR Partners LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CLDX overview All 13F holders of CLDX Full Q2 2026 holdings

Shares (Q2 2024): 0; Sold out in Q2 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2021

Holdings of CLDX by LMR Partners LLP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2024	0	$0	0.0%	−200,000−100.0%	Sold out	Holders
Q1 2024	200,000	$8.39M	0.2%	+200,000	New	Holders
Q2 2021	0	$0	0.0%	−25,352−100.0%	Sold out	Holders
Q1 2021	25,352	$522.0K	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.